Mevion Medical Systems delivered a superconducting synchrocyclotron accelerator for its Mevion S250 proton therapy system under installation at University Hospitals Seidman Cancer Center and UH Rainbow Babies & Children's Hospital in Cleveland.
The Leukemia & Lymphoma Society accelerated a portion of the final payment linked to the phase III study of CPX-351 (cytarabine:daunorubicin) liposome injection, Celator Pharmaceuticals' lead product candidate, for the treatment of patients with high-risk acute myeloid leukemia.
CYRUS GHAJAR received a $4.1 million Department of Defense Breast Cancer Research Program “Era of Hope” Scholar Award.
The LIVESTRONG Foundation announced two appointments to its senior leadership: Donna Palmer as chief development officer, and Katie Merrell as vice president of people.
GEORGE WILDING was named vice provost for clinical and interdisciplinary research at MD Anderson Cancer Center. His appointment will begin Sept. 1.
JONATHAN LICHT was appointed director of the University of Florida Health Cancer Center, effective Oct. 1.
The Cancer Letter won a first place 2015 National Press Club Award in the NPC's annual journalism competition June 26.
The European Medicines Agency granted accelerated approval to Opdivo (nivolumab) for the treatment of metastatic melanoma.
RAPHAEL POLLOCK was named surgeon-in-chief for The Ohio State University Health System.
The NCI Board of Scientific Advisors approved the following concepts at a meeting June 24:
